1 - 25 of
125
results
for author:"Inada T."
in Literature Citations
| Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients. Kishi T., Tsunoka T., Ikeda M., Kitajima T., Kawashima K., Okochi T., Okumura T., Yamanouchi Y., Kinoshita Y., Ujike H. et al. Neuropharmacology 0:0-0(2009) · Mapped (11) |
| Serotonin 1A receptor gene and major depressive disorder: an association study and meta-analysis. Kishi T., Tsunoka T., Ikeda M., Kawashima K., Okochi T., Kitajima T., Kinoshita Y., Okumura T., Yamanouchi Y., Inada T. et al. J. Hum. Genet. 0:0-0(2009) · Mapped (4) |
| Involvement of TORC2, a CREB co-activator, in the in vivo-specific transcriptional control of HTLV-1. Jiang S., Inada T., Tanaka M., Furuta R.A., Shingu K., Fujisawa J. Retrovirology 6:73-73(2009) · Mapped (4) |
| Association between neuropeptide Y gene and its receptor Y1 gene and methamphetamine dependence. Okahisa Y., Ujike H., Kotaka T., Morita Y., Kodama M., Inada T., Yamada M., Iwata N., Iyo M., Sora I. et al. Psychiatry Clin. Neurosci. 63:417-422(2009) · Mapped (4) |
| Association analyses between brain-expressed fatty-acid binding protein (FABP) genes and schizophrenia and bipolar disorder. Iwayama Y., Hattori E., Maekawa M., Yamada K., Toyota T., Ohnishi T., Iwata Y., Tsuchiya K.J., Sugihara G., Kikuchi M. et al. Am. J. Med. Genet. B Neuropsychiatr. Genet. 0:0-0(2009) · Mapped (5) |
| No association between polymorphisms of neuronal oxide synthase 1 gene (NOS1) and schizophrenia in a Japanese population. Okumura T., Okochi T., Kishi T., Ikeda M., Kitajima T., Yamanouchi Y., Kinoshita Y., Kawashima K., Tsunoka T., Ujike H. et al. Neuromolecular Med. 11:123-127(2009) · Mapped (5) |
| G72 gene is associated with susceptibility to methamphetamine psychosis. Kotaka T., Ujike H., Okahisa Y., Takaki M., Nakata K., Kodama M., Inada T., Yamada M., Uchimura N., Iwata N. et al. Prog. Neuropsychopharmacol. Biol. Psychiatry 33:1046-1049(2009) · Mapped (14) |
| A two-stage case-control association study of PADI2 with schizophrenia. Watanabe Y., Nunokawa A., Kaneko N., Arinami T., Ujike H., Inada T., Iwata N., Kunugi H., Itokawa M., Otowa T. et al. J. Hum. Genet. 54:430-432(2009) · Mapped (4) |
| Genetic association analysis of serotonin 2A receptor gene (HTR2A) with bipolar disorder and major depressive disorder in the Japanese population. Kishi T., Kitajima T., Tsunoka T., Ikeda M., Yamanouchi Y., Kinoshita Y., Kawashima K., Okochi T., Okumura T., Inada T. et al. Neurosci. Res. 64:231-234(2009) · Mapped (3) |
| BDNF is not associated with schizophrenia: data from a Japanese population study and meta-analysis. Kawashima K., Ikeda M., Kishi T., Kitajima T., Yamanouchi Y., Kinoshita Y., Okochi T., Aleksic B., Tomita M., Okada T. et al. Schizophr. Res. 112:72-79(2009) · Mapped (6) |
| Genetic association analysis of NRG1 with methamphetamine-induced psychosis in a Japanese population. Okochi T., Kishi T., Ikeda M., Kitajima T., Kinoshita Y., Kawashima K., Okumura T., Tsunoka T., Inada T., Yamada M. et al. Prog. Neuropsychopharmacol. Biol. Psychiatry 33:903-905(2009) · Mapped (26) |
| Association analysis of Group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese population. Tsunoka T., Kishi T., Ikeda M., Kitajima T., Yamanouchi Y., Kinoshita Y., Kawashima K., Okochi T., Okumura T., Inada T. et al. Prog. Neuropsychopharmacol. Biol. Psychiatry 33:875-879(2009) · Mapped (12) |
| A functional polymorphism in estrogen receptor alpha gene is associated with Japanese methamphetamine induced psychosis. Kishi T., Ikeda M., Kitajima T., Yamanouchi Y., Kinoshita Y., Kawashima K., Okochi T., Tsunoka T., Okumura T., Inada T. et al. Prog. Neuropsychopharmacol. Biol. Psychiatry 33:895-898(2009) · Mapped (53) |
| An association study of monoamine oxidase A (MAOA) gene polymorphism in methamphetamine psychosis. Nakamura K., Sekine Y., Takei N., Iwata Y., Suzuki K., Anitha A., Inada T., Harano M., Komiyama T., Yamada M. et al. Neurosci. Lett. 455:120-123(2009) · Mapped (9) |
| Involvement of SMARCA2/BRM in the SWI/SNF chromatin-remodeling complex in schizophrenia. Koga M., Ishiguro H., Yazaki S., Horiuchi Y., Arai M., Niizato K., Iritani S., Itokawa M., Inada T., Iwata N. et al. Hum. Mol. Genet. 18:2483-2494(2009) · Mapped (27) |
| Meta-analysis of association between genetic variants in COMT and schizophrenia: an update. Okochi T., Ikeda M., Kishi T., Kawashima K., Kinoshita Y., Kitajima T., Yamanouchi Y., Tomita M., Inada T., Ozaki N. et al. Schizophr. Res. 110:140-148(2009) · Mapped (8) |
| Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosis. Ujike H., Katsu T., Okahisa Y., Takaki M., Kodama M., Inada T., Uchimura N., Yamada M., Iwata N., Sora I. et al. Prog. Neuropsychopharmacol. Biol. Psychiatry 33:625-629(2009) · Mapped (69) |
| Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese population. Kishi T., Kitajima T., Ikeda M., Yamanouchi Y., Kinoshita Y., Kawashima K., Okochi T., Okumura T., Tsunoka T., Inada T. et al. Eur Arch Psychiatry Clin Neurosci 259:293-297(2009) · Mapped (7) |
| Nucleolar structure and function are regulated by the deubiquitylating enzyme USP36. Endo A., Matsumoto M., Inada T., Yamamoto A., Nakayama K.I., Kitamura N., Komada M. J. Cell. Sci. 122:678-686(2009) · Mapped (4) |
| Nascent peptide-dependent translation arrest leads to Not4p-mediated protein degradation by the proteasome. Dimitrova L.N., Kuroha K., Tatematsu T., Inada T. J. Biol. Chem. 284:10343-10352(2009) · Mapped (18) |
| The nucleosomal binding protein NSBP1 is highly expressed in the placenta and modulates the expression of differentiation markers in placental Rcho-1 cells. Shirakawa H., Rochman M., Furusawa T., Kuehn M.R., Horigome S., Haketa K., Sugita Y., Inada T., Komai M., Bustin M. J. Cell. Biochem. 106:651-658(2009) · Mapped (2) |
| Two-stage case-control association study of polymorphisms in rheumatoid arthritis susceptibility genes with schizophrenia. Watanabe Y., Nunokawa A., Kaneko N., Muratake T., Arinami T., Ujike H., Inada T., Iwata N., Kunugi H., Itokawa M. et al. J. Hum. Genet. 54:62-65(2009) · Mapped (28) |
| Supportive evidence for reduced expression of GNB1L in schizophrenia. Ishiguro H., Koga M., Horiuchi Y., Noguchi E., Morikawa M., Suzuki Y., Arai M., Niizato K., Iritani S., Itokawa M. et al. Schizophr Bull 0:0-0(2008) · Mapped (1) |
| Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression. Onaivi E.S., Ishiguro H., Gong J.P., Patel S., Meozzi P.A., Myers L., Perchuk A., Mora Z., Tagliaferro P.A., Gardner E. et al. Ann. N. Y. Acad. Sci. 1139:434-449(2008) · Mapped (5) |
| Prostate apoptosis response 4 gene is not associated with methamphetamine-use disorder in the Japanese population. Kishi T., Ikeda M., Kitajima T., Yamanouchi Y., Kinoshita Y., Kawashima K., Inada T., Harano M., Komiyama T., Hori T. et al. Ann. N. Y. Acad. Sci. 1139:83-88(2008) · Mapped (1) |
